Frédérique Jacobs
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 35
- Antibiotics Pharmacokinetics and Efficacy 35
- Epidemiology 29
- Pneumonia and Respiratory Infections 11
- Sepsis Diagnosis and Treatment 6
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Co-authors
- Jean‐Louis Vincent (29 shared papers)Fabio Silvio Taccone (32 shared papers)Daniel De Backer (13 shared papers)Frédéric Cotton (16 shared papers)Pierre Wallemacq (9 shared papers)Jason A. Roberts (8 shared papers)Isabelle Delattre (8 shared papers)Pierre‐François Laterre (8 shared papers)
In The Last Decade
Frédérique Jacobs
70 papers receiving 3.4k citations
Frédérique Jacobs's Hit Papers
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 489
- Pharmacology 1.5k
- Molecular Medicine 446
- Infectious Diseases 925
- Clinical Biochemistry 308
Countries citing papers authored by Frédérique Jacobs
This map shows the geographic impact of Frédérique Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Jacobs more than expected).
Fields of papers citing papers by Frédérique Jacobs
This network shows the impact of papers produced by Frédérique Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Jacobs. The network helps show where Frédérique Jacobs may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédérique Jacobs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Hit paper breakdown → | 2007 | 515 |
| 2 | 2010 | 288 | |
| 3 | 1999 | 204 | |
| 4 | 2011 | 176 | |
| 5 | 2011 | 162 | |
| 6 | 2010 | 152 | |
| 7 | Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. | 2006 | 115 |
| 8 | 2013 | 101 | |
| 9 | 2014 | 86 | |
| 10 | 2017 | 85 | |
| 11 | 2017 | 83 | |
| 12 | 2012 | 82 | |
| 13 | 2014 | 71 | |
| 14 | 2014 | 71 | |
| 15 | 2012 | 70 | |
| 16 | 2012 | 67 | |
| 17 | 2010 | 65 | |
| 18 | 2012 | 50 | |
| 19 | 2012 | 47 | |
| 20 | 2018 | 47 |
About Frédérique Jacobs
Frédérique Jacobs is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 73 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Pneumonia and Respiratory Infections (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antibiotic Use and Resistance (7 papers), Sepsis Diagnosis and Treatment (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (489 citations), Pharmacology (1.5k citations), Molecular Medicine (446 citations), Infectious Diseases (925 citations) and Clinical Biochemistry (308 citations). Frédérique Jacobs has collaborated with scholars based in Belgium, France and Australia. Frequent co-authors include Jean‐Louis Vincent, Fabio Silvio Taccone, Daniel De Backer, Frédéric Cotton, Pierre Wallemacq, Jason A. Roberts, Isabelle Delattre, Pierre‐François Laterre, Maya Hites and Thierry Dugernier. Their work appears in journals such as International Journal of Antimicrobial Agents, Antimicrobial Agents and Chemotherapy, Critical Care, Critical Care Medicine and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.